ASHPOfficial

This podcast will focus on the perspective of two clinical pharmacy specialists who have experience with developing clinical pharmacy services in either new pediatric emergency departments or established ones that never had a designated clinical pharmacist. This podcast episode will help future pharmacists prepare for the process of establishing new clinical services and receive helpful tips and tricks to be successful specifically in a pediatric emergency department.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, presenters from the 2022 Midyear Clinical Meeting analyze the difference between race, ancestry, and genetics and how the over-simplification of race in clinical practice and education can propagate healthcare disparities and how pharmacists can address these to improve patient care.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode from the 2022 Midyear Clinical Meeting, our content matter experts discuss digital health interventions currently used by pharmacists and identify monitoring opportunities for pharmacists.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast provides listeners with an overview of how professional policies are developed within ASHP. Members from ASHP’s councils, the primary bodies that initiate ASHP policies on professional issues, discuss their roles and share ways new practitioners can get involved in supporting professional policy development.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode from the Midyear 2022 Clinical Meeting, our content matter experts summarize the rationale for the development of an organizational medication safety dashboard and provide real-world examples of metric design, data source identification, and data visualization for a medication safety dashboard. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Measles is a harmful yet preventable disease that carries multiple sequelae requiring hospitalization. Due to falsified and retracted literature, the measles vaccine may be viewed as a cause of autism, which is categorically untrue. This has led to increased global morbidity and misinformation about the safety and efficacy of vaccines, including the measles vaccine.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this Management Case Study from the 2022 Midyear Clinical Meeting, content matter experts describe the process for developing an enterprise-wide acute hospital at home (AHH) program and identify the risks and benefits of AHH for the healthcare organization.as well as patients and caregivers.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join us for a discussion of real-world examples for incorporating wellness activities into organizational efforts to support individual well-being and resilience. Guests will also discuss a vision for leveraging the pharmacy workforce in wellness-related patient care services as a means to promote health and advance the profession. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, Dr. Stephen Small and Dr. Regis Lucia discuss the AJHP Commentary, “Obstetric clinical pharmacy: A necessary birth of a new specialty,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this feature from 2022 Midyear Clinical Meeting, our content matter expert reviews key data analytics techniques, including machine learning, to promote drug diversion program best practices.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.